The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The site-specific incorporation efficiency of unnatural amino acids (UAAs) is strongly affected by a number of factors, including the degeneracy of surrounding codons, residue packing areas, and solvent exposure (70)(71)(72).”
From Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease (2020) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
Sletten, E. M., & Bertozzi, C. R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900942 · Cited by 3,165
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161 · cited 2×
“The use of therapeutic antibodies is reviewed elsewhere (Leader et al., 2008).”
BackgroundAdding New Chemistries to the Genetic Code
Liu, C. C., & Schultz, P. G. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.105824 · Cited by 1,725 · cited 2×
“The list of UAAs incorporated into proteins is rapidly growing and other papers review list the growing number of UAAs that can be incorporated in this manner (Budisa, 2004; Hendrickson et al., 2004; Liu and Schultz, 2010; Neumann, 2012).”
BackgroundCu-free click cycloaddition reactions in chemical biology
Jewett, J. C., & Bertozzi, C. R. (2010) · Chemical Society Reviews · doi:10.1039/b901970g · Cited by 1,684 · cited 1×
“Next they coupled the two bifunctional linkers to obtain the bispecific antibody by a copper-free [3 + 2] Huisgen cycloaddition (Jewett and Bertozzi, 2010).”
MethodA General Method for Site-specific Incorporation of Unnatural Amino Acids into Proteins
Noren, C. J., Anthony-Cahill, S. J., Griffith, M. C., & Schultz, P. G. (1989) · Science · doi:10.1126/science.2649980 · Cited by 1,019 · cited 2×
“REVIEW ARTICLE published: 01 April 2014 doi: 10.3389/fchem.2014.00015 Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins”
BackgroundMethodInfluentialEncoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome
Neumann, H., Wang, K., Davis, L., Garcia-Alai, M., & Chin, J. W. (2010) · Nature · doi:10.1038/nature08817 · Cited by 622
Delivery of Therapeutic Proteins
Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22054 · Cited by 532
Bispecific antibodies for cancer therapy: The light at the end of the tunnel?
Chames, P., & Baty, D. (2009) · mAbs · doi:10.4161/mabs.1.6.10015 · Cited by 336 · cited 3×
“Although none of the reported antibodies are capable of curing cancer as a single agent, (Chames and Baty, 2009) specific antibodies can improve the clinical outcome of cancer, autoimmune disease, transplant rejection or can bind toxins (e.g., snake venom toxins).”
Background
Research works printed but not linked: 87
- Anderson, 2002, Exploring the limits of codon and anticodon size, Chem. Biol, 9, 237, 10.1016/S1074-5521(02)00094-7 · DOI
- Armen, 2010, Steric and thermodynamic limits of design for the incorporation of large unnatural amino acids in aminoacyl-tRNA synthetase enzymes, Proteins, 78, 1926, 10.1002/prot.22706 · doi:10.1002/prot.22706
- Axup, 2012, Synthesis of site-specific antibody-drug conjugates using unnatural amino acids, Proc. Natl. Acad. Sci. U.S.A, 109, 16101, 10.1073/pnas.1211023109 · DOI · Paper page
- Banta, 2013, Replacing antibodies: engineering new binding proteins, Annu. Rev. Biomed. Eng, 15, 93, 10.1146/annurev-bioeng-071812-152412 · DOI
- Bayly, 2002, Large-scale bacterial fermentation and isolation of scFv multimers using a heat-inducible bacterial expression vector, J. Immunol. Methods, 262, 217, 10.1016/S0022-1759(02)00021-2 · DOI
- Bernardes, 2012, A traceless vascular-targeting antibody-drug conjugate for cancer therapy, Angew. Chem. Int. Ed. Engl, 51, 941, 10.1002/anie.201106527 · DOI
- Best, 2009, Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules, Biochemistry, 48, 6571, 10.1021/bi9007726 · DOI · Paper page
- Boder, 2000, Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity, Proc. Natl. Acad. Sci. U.S.A, 97, 10701, 10.1073/pnas.170297297 · DOI · Paper page
- Budisa, 2004, Prolegomena to future experimental efforts on genetic code engineering by expanding its amino acid repertoire, Angew. Chem. Int. Ed. Engl, 43, 6426, 10.1002/anie.200300646 · DOI · Paper page
- Cellitti, 2008, In vivo incorporation of unnatural amino acids to probe structure, dynamics, and ligand binding in a large protein by nuclear magnetic resonance spectroscopy, J. Am. Chem. Soc, 130, 9268, 10.1021/ja801602q · DOI · Paper page
- Chari, 2008, Targeted cancer therapy: conferring specificity to cytotoxic drugs, Acc. Chem. Res, 41, 98, 10.1021/ar700108g · DOI · Paper page
- Chatterjee, 2013, A versatile platform for single- and multiple-unnatural amino acid mutagenesis in Escherichia coli., Biochemistry, 52, 1828, 10.1021/bi4000244 · DOI · Paper page
- Cho, 2011, Optimized clinical performance of growth hormone with an expanded genetic code, Proc. Natl. Acad. Sci. U.S.A, 108, 9060, 10.1073/pnas.1100387108 · DOI · Paper page
- Cho, 2003, Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab, Nature, 421, 756, 10.1038/nature01392 · DOI · Paper page
- Choe, 2003, Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120, Cell, 114, 161, 10.1016/S0092-8674(03)00508-7 · DOI · Paper page
- Daniels, 2006, The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer, Clin. Immunol, 121, 144, 10.1016/j.clim.2006.06.010 · DOI · Paper page
- de Graaf, 2009, Nonnatural amino acids for site-specific protein conjugation, Bioconjug. Chem, 20, 1281, 10.1021/bc800294a · DOI · Paper page
- Deiters, 2004, Site-specific PEGylation of proteins containing unnatural amino acids, Bioorg. Med. Chem. Lett, 14, 5743, 10.1016/j.bmcl.2004.09.059 · DOI · Paper page
- de Oliveira, 1999, High-yield purification of biosynthetic human growth hormone secreted in Escherichia coli periplasmic space, J. Chromatogr. A, 852, 441, 10.1016/S0021-9673(99)00613-5 · doi:10.1016/s0021-9673(99)00613-5
- Dhomen, 2012, Therapeutic targeting of the epidermal growth factor receptor in human cancer, Crit. Rev. Oncog, 17, 31, 10.1615/CritRevOncog.v17.i1.40 · doi:10.1615/critrevoncog.v17.i1.40
- Gerdes, 2003, Experimental determination and system level analysis of essential genes in Escherichia coli MG1655, J. Bacteriol, 185, 5673, 10.1128/JB.185.19.5673-5684.2003 · DOI · Paper page
- Guzman, 1995, Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter, J. Bacteriol, 177, 4121, 10.1128/jb.177.14.4121-4130.1995 · DOI · Paper page
- Hakim, 2009, “Inclonalsâ€: IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding system, MAbs, 1, 281, 10.4161/mabs.1.3.8492 · DOI
- Hendrickson, 2004, Incorporation of nonnatural amino acids into proteins, Annu. Rev. Biochem, 73, 147, 10.1146/annurev.biochem.73.012803.092429 · DOI · Paper page
- Hermeling, 2004, Structure-immunogenicity relationships of therapeutic proteins, Pharm. Res, 21, 897, 10.1023/B:PHAM.0000029275.41323.a6 · DOI · Paper page
- Hoogenboom, 2005, Selecting and screening recombinant antibody libraries, Nat. Biotechnol, 23, 1105, 10.1038/nbt1126 · DOI · Paper page
- Huang, 2012, Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements, J. Ind. Microbiol. Biotechnol, 39, 383, 10.1007/s10295-011-1082-9 · DOI · Paper page
- Isaacs, 2011, Precise manipulation of chromosomes in vivo enables genome-wide codon replacement, Science, 333, 348, 10.1126/science.1205822 · DOI · Paper page
- Johnson, 2012, Release factor one is nonessential in Escherichia coli, ACS Chem. Biol, 7, 1337, 10.1021/cb300229q · DOI
- Johnson, 2011, RF1 knockout allows ribosomal incorporation of unnatural amino acids at multiple sites, Nat. Chem. Biol, 7, 779, 10.1038/nchembio.657 · DOI · Paper page
- Jung, 2011, Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy, Curr. Opin. Biotechnol, 22, 858, 10.1016/j.copbio.2011.03.002 · DOI
- Junutula, 2008, Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index, Nat. Biotechnol, 26, 925, 10.1038/nbt.1480 · DOI · Paper page
- Kim, 2012, Synthesis of bispecific antibodies using genetically encoded unnatural amino acids, J. Am. Chem. Soc, 134, 9918, 10.1021/ja303904e · DOI · Paper page
- Kruszewska, 2008, Alterations in protein secretion caused by metabolic engineering of glycosylation pathways in fungi, Acta Biochim. Pol, 55, 447, 10.18388/abp.2008_3050 · doi:10.18388/abp.2008_3050
- Li, 2006, Optimization of humanized IgGs in glycoengineered Pichia pastoris, Nat. Biotechnol, 24, 210, 10.1038/nbt1178 · DOI · Paper page
- Lim, 2010, Bioorthogonal chemistry: recent progress and future directions, Chem. Commun. (Camb.), 46, 1589, 10.1039/b925931g · DOI · Paper page
- Liu, 2007, Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin, J. Am. Chem. Soc, 129, 10648, 10.1021/ja0735002 · DOI
- Liu, 2009a, Mutagenesis and evolution of sulfated antibodies using an expanded genetic code, Biochemistry, 48, 8891, 10.1021/bi9011429 · DOI
- Liu, 2009b, Evolution of proteins with genetically encoded “chemical warheads.â€, J. Am. Chem. Soc, 131, 9616, 10.1021/ja902985e · DOI
- Liu, 2008, Protein evolution with an expanded genetic code, Proc. Natl. Acad. Sci. U.S.A, 105, 17688, 10.1073/pnas.0809543105 · DOI
- Lopes, 2010, LPS removal from an E. coli fermentation broth using aqueous two-phase micellar system, Biotechnol. Prog, 26, 1644, 10.1002/btpr.463 · doi:10.1002/btpr.463
- Makino, 2011, Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies, Metab. Eng, 13, 241, 10.1016/j.ymben.2010.11.002 · DOI
- Mazor, 2010, Selection of full-length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence-activated cell sorting screening, FEBS J, 277, 2291, 10.1111/j.1742-4658.2010.07645.x · DOI
- Mazor, 2008, E-clonal antibodies: selection of full-length IgG antibodies using bacterial periplasmic display, Nat. Protoc, 3, 1766, 10.1038/nprot.2008.176 · DOI
- Mazor, 2007, Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli, Nat. Biotechnol, 25, 563, 10.1038/nbt1296 · DOI · Paper page
- Melancon, 2009, One plasmid selection system for the rapid evolution of aminoacyl-tRNA synthetases, Bioorg. Med. Chem. Lett, 19, 3845, 10.1016/j.bmcl.2009.04.007 · DOI
- Meldal, 2008, Cu-catalyzed azide-alkyne cycloaddition, Chem. Rev, 108, 2952, 10.1021/cr0783479 · DOI · Paper page
- Mukai, 2010, Codon reassignment in the Escherichia coli genetic code, Nucleic Acids Res, 38, 8188, 10.1093/nar/gkq707 · DOI · Paper page
- Nakamura, 2000, Codon usage tabulated from international DNA sequence databases: status for the year 2000, Nucleic Acids Res, 28, 292, 10.1093/nar/28.1.292 · DOI · Paper page
- Neumann, 2012, Rewiring translation—Genetic code expansion and its applications, FEBS Lett, 586, 2057, 10.1016/j.febslet.2012.02.002 · DOI
- Neumann, 2009, A method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation, Mol. Cell, 36, 153, 10.1016/j.molcel.2009.07.027 · DOI · Paper page
- Neumann, 2008, Genetically encoding N(epsilon)-acetyllysine in recombinant proteins, Nat. Chem. Biol, 4, 232, 10.1038/nchembio.73 · DOI · Paper page
- Nguyen, 2009, Genetically encoding N(epsilon)-methyl-L-lysine in recombinant histones, J. Am. Chem. Soc, 131, 14194, 10.1021/ja906603s · DOI · Paper page
- Normanly, 1990, Construction of Escherichia coli amber suppressor tRNA genes. III. Determination of tRNA specificity, J. Mol. Biol, 213, 719, 10.1016/S0022-2836(05)80258-X · DOI
- Payne, 2011, Product development issues for PEGylated proteins, Pharm. Dev. Technol, 16, 423, 10.3109/10837450.2010.513990 · DOI
- Plumbridge, 1987, The effect of dam methylation on the expression of glnS in E. coli. Biochimie, 69, 539, 10.1016/0300-9084(87)90091-5 · doi:10.1016/0300-9084(87)90091-5
- Prescher, 2005, Chemistry in living systems, Nat. Chem. Biol, 1, 13, 10.1038/nchembio0605-13 · DOI · Paper page
- Rackham, 2005, A network of orthogonal ribosome x mRNA pairs, Nat. Chem. Biol, 1, 159, 10.1038/nchembio719 · DOI · Paper page
- Ryu, 2006, Efficient incorporation of unnatural amino acids into proteins in Escherichia coli, Nat. Methods, 3, 263, 10.1038/nmeth864 · DOI · Paper page
- Salinas, 2011, Tuned Escherichia coli as a host for the expression of disulfide-rich proteins, Biotechnol. J, 6, 686, 10.1002/biot.201000335 · DOI
- Santoro, 2002, An efficient system for the evolution of aminoacyl-tRNA synthetase specificity, Nat. Biotechnol, 20, 1044, 10.1038/nbt742 · DOI · Paper page
- Schwarz, 2010, A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation, Nat. Chem. Biol, 6, 264, 10.1038/nchembio.314 · DOI · Paper page
- Scolnick, 1968, Release factors differing in specificity for terminator codons, Proc. Natl. Acad. Sci. U.S.A, 61, 768, 10.1073/pnas.61.2.768 · DOI · Paper page
- Seliger, 2008, Molecular mechanisms of MHC class I abnormalities and APM components in human tumors, Cancer Immunol. Immunother, 57, 1719, 10.1007/s00262-008-0515-4 · DOI
- Senter, 2009, Potent antibody drug conjugates for cancer therapy, Curr. Opin. Chem. Biol, 13, 235, 10.1016/j.cbpa.2009.03.023 · DOI · Paper page
- Sharpless, 2002, Searching for new reactivity (Nobel lecture), Angew. Chem. Int. Ed. Engl, 41, 2024, 10.1002/1521-3773(20020617)41:12%3C2024::AID-ANIE2024%3E3.0.CO;2-O · doi:10.1002/1521-3773(20020617)41:12<2024::aid-anie2024>3.0.co;2-o
- Shen, 2012, Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates, Nat. Biotechnol, 30, 184, 10.1038/nbt.2108 · DOI · Paper page
- Stadtman, 1996, Selenocysteine, Annu. Rev. Biochem, 65, 83, 10.1146/annurev.bi.65.070196.000503 · DOI · Paper page
- Steer, 1999, Major anticodon-binding region missing from an archaebacterial tRNA synthetase, J. Biol. Chem, 274, 35601, 10.1074/jbc.274.50.35601 · DOI
- Strohl, 2009, Discovery and development of biopharmaceuticals: current issues, Curr. Opin. Biotechnol, 20, 668, 10.1016/j.copbio.2009.10.012 · DOI
- Takimoto, 2011, Stereochemical basis for engineered pyrrolysyl-tRNA synthetase and the efficient in vivo incorporation of structurally divergent non-native amino acids, ACS Chem. Biol, 6, 733, 10.1021/cb200057a · DOI
- Terra, 2012, Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design, J. Med. Microbiol, 61, 919, 10.1099/jmm.0.039438-0 · DOI
- Veronese, 2002, Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation, Adv. Drug Deliv. Rev, 54, 587, 10.1016/S0169-409X(02)00029-7 · DOI · Paper page
- Virdee, 2011, Traceless and site-specific ubiquitination of recombinant proteins, J. Am. Chem. Soc, 10.1021/ja202799r · DOI · Paper page
- Virdee, 2010, Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase, Nat. Chem. Biol, 6, 750, 10.1038/nchembio.426 · DOI · Paper page
- Wacker, 2002, N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli., Science, 298, 1790, 10.1126/science.298.5599.1790 · DOI · Paper page
- Wang, 2007, Evolved orthogonal ribosomes enhance the efficiency of synthetic genetic code expansion, Nat. Biotechnol, 25, 770, 10.1038/nbt1314 · DOI · Paper page
- Wang, 2012, Reprogramming the genetic code: from triplet to quadruplet codes, Angew. Chem. Int. Ed. Engl, 51, 2288, 10.1002/anie.201105016 · DOI
- Wang, 2001, Expanding the genetic code of Escherichia coli, Science, 292, 498, 10.1126/science.1060077 · DOI · Paper page
- Wang, 2001, A general approach for the generation of orthogonal tRNAs, Chem. Biol, 8, 883, 10.1016/S1074-5521(01)00063-1 · DOI · Paper page
- Wang, 2003, Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition, J. Am. Chem. Soc, 125, 3192, 10.1021/ja021381e · DOI · Paper page
- Winter, 2001, Increased production of human proinsulin in the periplasmic space of Escherichia coli by fusion to DsbA, J. Biotechnol, 84, 175, 10.1016/S0168-1656(00)00356-4 · DOI
- Xie, 2005a, Adding amino acids to the genetic repertoire, Curr. Opin. Chem. Biol, 9, 548, 10.1016/j.cbpa.2005.10.011 · DOI · Paper page
- Xie, 2005b, An expanding genetic code, Methods, 36, 227, 10.1016/j.ymeth.2005.04.010 · DOI
- Young, 2011, An evolved aminoacyl-tRNA synthetase with atypical polysubstrate specificity, Biochemistry, 50, 1894, 10.1021/bi101929e · DOI · Paper page
- Young, 2010, An enhanced system for unnatural amino acid mutagenesis in E. coli., J. Mol. Biol, 395, 361, 10.1016/j.jmb.2009.10.030 · DOI · Paper page
- Zhu, 1995, Identification of heavy chain residues in a humanized anti-CD3 antibody important for efficient antigen binding and T cell activation, J. Immunol, 155, 1903, 10.4049/jimmunol.155.4.1903 · DOI
Cited by
Srinivasarao, M., & Low, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00013 · Cited by 605
Contemporary approaches to site-selective protein modification
Hoyt, E. A., Cal, P. M. S. D., Oliveira, B. L., & Bernardes, G. J. L. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0079-1 · Cited by 537
Engineering protein-based therapeutics through structural and chemical design
Ebrahimi, S. B., & Samanta, D. (2023) · Nature Communications · doi:10.1038/s41467-023-38039-x · Cited by 382
Recent trends in protein and peptide-based biomaterials for advanced drug delivery
Varanko, A., Saha, S., & Chilkoti, A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.08.008 · Cited by 369
Boronic acids as building blocks for the construction of therapeutically useful bioconjugates
António, J. P. M., Russo, R., Carvalho, C. P., Cal, P. M. S. D., & Gois, P. M. P. (2019) · Chemical Society Reviews · doi:10.1039/c9cs00184k · Cited by 303
Metadata
- Authors
- Wals, K., & Ovaa, H.
- Venue
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Published
- 2014-04-01
- Volume
- 2
- ISSN
- 2296-2646
- Cited by
- 120
- References
- 8
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins. https://app.cochat.ai/papers/10.3389/fchem.2014.00015
- The paper
- Wals, K., & Ovaa, H. (2014). Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins. Frontiers in Chemistry. https://doi.org/10.3389/fchem.2014.00015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.